Pediatric FDG PET/CT: Physiologic Uptake, Normal Variants, and Benign Conditions

被引:100
作者
Shammas, Amer [1 ]
Lim, Ruth [1 ]
Charron, Martin [1 ]
机构
[1] Univ Toronto, Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada
关键词
POSITRON-EMISSION-TOMOGRAPHY; BROWN ADIPOSE-TISSUE; COLONY-STIMULATING FACTOR; STANDARDIZED UPTAKE VALUE; ATTENUATION CORRECTION; F-18-FDG PET/CT; INTRAVENOUS CONTRAST; INJECTION SITE; MUSCLE UPTAKE; PITFALLS;
D O I
10.1148/rg.295085247
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-d-glucose (FDG) is increasingly being used in the evaluation of pediatric oncology patients. However, the normal distribution of F-18 FDG uptake in children is unique and may differ from that in adults. A number of physiologic variants are commonly encountered, including normal physiologic uptake in the head and neck, heart, breast, thymus, liver, spleen, gastrointestinal tract, genital system, urinary collecting system, bone marrow, muscles, and brown adipose tissue. Benign lesions with increased F-18 FDG uptake are also frequently seen and can be misinterpreted as malignancies. In addition, the use of combined PET/computed tomographic (CT) scanners is associated with pitfalls and artifacts such as attenuation correction and misregistration. Proper interpretation of pediatric F-18 FDG PET/CT studies requires knowledge of the normal distribution of F-18 FDG uptake in children, as well as of the aforementioned physiologic variants, benign lesions, and PET/CT-related artifacts. Knowing these potential causes of misinterpretation can increase accuracy in PET image interpretation, decrease the number of unnecessary follow-up studies or procedures, and improve patient treatment. (C) RSNA, 2009. radiographics.rsna.org
引用
收藏
页码:1467 / U314
页数:21
相关论文
共 61 条
[1]  
Abouzied MM, 2005, J NUCL MED TECHNOL, V33, P145
[2]   Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology Part II.: The clinical value in detecting and staging primary tumours [J].
Ak, I ;
Stokkel, MPM ;
Pauwels, EKJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (10) :560-574
[3]   Positron emission tomography imaging in nonmalignant thoracic disorders [J].
Alavi, A ;
Gupta, N ;
Alberini, JL ;
Hickeson, M ;
Adam, LE ;
Bhargava, P ;
Zhuang, HM .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) :293-321
[4]   18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst:: False-positive PET/CT in a patient with cervical carcinoma [J].
Ames, J ;
Blodgett, T ;
Meltzer, C .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (04) :1057-1059
[5]   FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions [J].
Aoki, J ;
Watanabe, H ;
Shinozaki, T ;
Takagishi, K ;
Ishijima, H ;
Oya, N ;
Sato, N ;
Inoue, T ;
Endo, K .
RADIOLOGY, 2001, 219 (03) :774-777
[6]   Guidelines for the use of PET-CT in children [J].
Barrington, Sally F. ;
Begent, Joanna ;
Lyunch, Thomas ;
Schleyer, Paul ;
Biassoni, Lorenzo ;
Ramsden, William ;
Kane, Thomas ;
Stoneham, Sara ;
Brooks, Margaret ;
Hain, Sharon F. .
NUCLEAR MEDICINE COMMUNICATIONS, 2008, 29 (05) :418-424
[7]  
Barrington SF, 1996, J NUCL MED, V37, P1127
[8]   PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients [J].
Berthelsen, AK ;
Holm, S ;
Loft, A ;
Klausen, TL ;
Andersen, F ;
Hojgaard, L .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) :1167-1175
[9]  
Brink I, 2001, J NUCL MED, V42, P591
[10]  
Brix G, 2005, J NUCL MED, V46, P608